Ligand profile
ZINC3069640
Virtual-screening candidate from ZINC.
Bound to: VK055_1513 — dihydroorotate dehydrogenase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC3069640- UniProt (similar protein)
Q02127- Tanimoto
- 0.829
- Target protein
- VK055_1513
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 38.8
- −1 ≤ LogP ≤ 5 2.83
- MW ≤ 500 Da 273.3
- LogP ≤ 5 2.83
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 38.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(/C=C/c1ccc2c(c1)OCO2)N1CCCCCC1O=C(/C=C/c1ccc2c(c1)OCO2)N1CCCCCC1
InChI=1S/C16H19NO3/c18-16(17-9-3-1-2-4-10-17)8-6-13-5-7-14-15(11-13)20-12-19-14/h5-8,11H,1-4,9-10,12H2/b8-6+InChI=1S/C16H19NO3/c18-16(17-9-3-1-2-4-10-17)8-6-13-5-7-14-15(11-13)20-12-19-14/h5-8,11H,1-4,9-10,12H2/b8-6+
AOJRYGWJYSVMPW-SOFGYWHQSA-NAOJRYGWJYSVMPW-SOFGYWHQSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- AYR
- Homolog
- Q02127
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC3069640 →
- ZINC ZINC20 ZINC3069640 →
- UniProt UniProt Q02127 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC3069640”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_1513.
PDB 75
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).